In Phase 3, Low Sodium Alternative to Xyrem Achieves Primary and Secondary Endpoints
Positive data from the Phase 3 study of Jazz Pharmaceuticals plc’s investigational medicine,...
Read MorePositive data from the Phase 3 study of Jazz Pharmaceuticals plc’s investigational medicine,...
Read MoreWhen it comes to sleep, the daily amount, quality, and regularity of bed/wake time all seem to matter, reports the Harvard Health Blog.A recent paper in Current Biology shows that our sleep is not very...
Read MoreAlthough the results do not support the routine prescription of hypnotic medication for mitigating suicidal ideation in all depressed outpatients with insomnia, they suggest that coprescription of a hypnotic during initiation of...
Read MoreRevealed at the CES tradeshow in January 2019, Philips expanded SmartSleep suite of...
Read MoreIn patients with high blood pressure resistant to treatment who also have obstructive sleep apnea...
Read More